Sofinnova Partners leads Series B round for Green Biologics
Green Biologics Ltd said Monday that it has received £15.4 million in Series B funding. Sofinnova Partners led the round with participation from Swire Pacific Limited, Capricorn Venture Partners, Oxford Capital Partners, Morningside Ventures and ConvergInce Holdings. Based in the UK, Green Biologics is a industrial biotechnology company.
2 December 2013•4 mins read
